Medixall Group

Medixall Group FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Medixall Group (MDXL) as of Nov 4, 2026 is 26.94 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 52.16 % — a change of -48.34% (lower).

FCF Conversion

26.94 %

YoY

-48.34%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Medixall Group is 2024 26.94 % . FCF Conversion Rate (FCF/EBITDA) of Medixall Group was 2023 52.16 % . It decreases by -48.34% lower compared to the previous year.

The Medixall Group FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2017
136.84 USD
Jan 1, 2018
84.02 USD
Jan 1, 2019
68.92 USD
Jan 1, 2020
60.60 USD
Jan 1, 2021
77.85 USD
Jan 1, 2022
52.16 USD
Jan 1, 2023
52.16 USD
Jan 1, 2024
26.94 USD
The Medixall Group FCF Conversion history
YEARFCF ConversionYoY
26.94 %-48.34%
52.16 %0.00%
52.16 %-33.00%
77.85 %+28.46%
60.60 %-12.07%
68.92 %-17.97%
84.02 %-38.60%
136.84 %+32.70%
103.12 %-2,840.47%
-3.76 %-153.14%
7.08 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medixall Group Stock analysis

What does Medixall Group do? The Medixall Group Inc is a company specialized in providing healthcare products and services. It was founded in 2016 and is headquartered in Fort Lauderdale, Florida. The company's business model is based on building an online platform to provide patients with quick and easy access to healthcare services. The goal is to improve access to high-quality services and products while reducing costs for patients. The Medixall Group Inc is divided into various divisions including telemedicine, clinical services, clinic management, and medical devices. The telemedicine division allows patients to receive medical care from home. The company provides a platform where patients can communicate in real-time with doctors and other medical professionals. They can receive diagnoses, recommendations for treatment, prescriptions, and follow-up care. The clinic management division provides management software to help medical facilities optimize their operations and reduce costs. The software enables facilities to use their resources more effectively and ensure better quality of medical care. The clinical services include a variety of medical services such as laboratory services, diagnostics, prevention, and counseling. The Medixall Group Inc works with qualified medical professionals to ensure the best possible medical care. The medical devices division offers a wide range of medical equipment and materials including diagnostic and treatment products for diseases and injuries. The Medixall Group Inc has already launched a variety of successful products. This includes the telemedicine platform TelDoctor, which allows patients to access a wide range of medical services. The company also offers an FDA-approved finger clip pulse oximeter, which measures oxygen levels in the blood and can be used in various medical applications. In summary, the Medixall Group Inc is an innovative company that aims to improve access to high-quality healthcare services while reducing costs for patients. They integrate technology and medical professionals to provide the best possible medical care. Medixall Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medixall Group stock

FCF Conversion Rate (FCF/EBITDA) of Medixall Group is 26.94 % in 2024.

FCF Conversion Rate (FCF/EBITDA) of Medixall Group changed from 52.16 % to 26.94 %, representing a -48.34% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Medixall Group since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Medixall Group with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Medixall Group

All Key Metrics — Medixall Group